Lousson J P
Ann Pharm Fr. 1995;53(2):79-82.
EDI is the technique the most frequently used by Chemists to relay their daily orders to their suppliers. Three out of four Chemists in France are computerised using various forms of computer hardware and software. The Health Care organisations propose that Chemists use the EDI to relay to the CETELIC all the items of information concerning their invoicing. This means handing over administrative information identifying the patient, the doctor ... as well as financial and confidential data such as the CIP code of the prescribed and delivered medicine. The law of the 4th January 1993 was instigated to control the rising expenses of the Health Care organisations and it mandates the Caisse Primaire d'Assurance Maladie (the French social security organisations) to retrieve and analyse the information thus gathered from all of the medical professionals involved. However, the accumulation of all these items of computerised information constitutes in effect a confidential medical file on each patient. This raises the following issues: Who does this confidential data belong to? Who should the Chemists give it to? What is to be done with it? Who will be responsible for its analysis in respect of the confidentiality problem? (Another medical professional bound by oath?) And how can we insure against subsequent abuse of this material?
电子数据交换（EDI）是化学家们向供应商传达日常订单时最常用的技术。法国四分之三的化学家使用各种形式的计算机硬件和软件实现了计算机化。医疗保健机构建议化学家们使用电子数据交换向CETELIC传达所有与发票相关的信息。这意味着要交出识别患者、医生等的管理信息，以及诸如所开处方和所交付药品的CIP代码等财务和机密数据。1993年1月4日的法律旨在控制医疗保健机构不断上涨的费用，它授权基础医疗保险基金（法国社会保障组织）检索和分析从所有相关医疗专业人员那里收集到的信息。然而，所有这些计算机化信息的积累实际上构成了每个患者的一份机密医疗档案。这引发了以下问题：这些机密数据属于谁？化学家们应该把它交给谁？如何处理这些数据？就保密问题而言，谁将负责对其进行分析？（另一位受誓言约束的医疗专业人员？）以及我们如何防止这些材料随后被滥用？
